Our mission is to accelerate translational research by improving the reproducibility rate of preclinical trials, improving the success rate of clinical trials and decreasing the development time.
The Duke Preclinical Translational Research Unit (PTRU) provides:
- Preclinical and translational research services, including cancer and non-cancer related applications that enable investigators (both inside and outside Duke) to conduct critical in vivo experiments.
- Highly skilled input and oversight from Duke experts in cancer biology, pharmacokinetics, animal experimentation, medical devices, physiology, imaging, statistics, and regulatory support.
- High-quality data documentation that delivers sound statistical design, clinical relevance, data integrity, efficient resource usage, and commercial viability.